| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/2004 | US20040152901 Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/05/2004 | US20040152900 Method for the isolation of sulfuric acid mono-[3({1-[2-(4-fluorophenyly)-ethyl]-piperidin-4-yl}-2-methoxy-phenyl}ester |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152892 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152889 Process for the preparation of benazepril |
| 08/05/2004 | US20040152888 novel benzodiazepine derivatives |
| 08/05/2004 | US20040152787 Primary aliphatic c24-30 alcohols from the wax secreted by the insect ericerus pela; tetracosanol, hexacosanol, octacosanol and triacontanol; treatment of obesity, syndrome x, diabetes, hypercholesterolemia, ischemia, thrombosis, atherosclerosis |
| 08/05/2004 | US20040152786 Preventive or remedy for diseases caused by cerebrovascular disturbances |
| 08/05/2004 | US20040152784 Mixture of sodium phenylbutyric acid, flavoring and artificial sweetening |
| 08/05/2004 | US20040152783 Mixture of liothyronine and thyroxine; sustained release; therapy for glandular disorders; antidepressants; obesity; congestive heart fialure; psychological disorders |
| 08/05/2004 | US20040152782 Acylation of a suitable salt of D-phenylalanine with trans-4-isopropylcyclohexane acid chloride in both a single and a two phase system |
| 08/05/2004 | US20040152781 Use of acetyl l-carnitine for the prepartion of a medication for the preventive therapy for pain |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152778 Treatment of polyglutamine disorders caused by expanding genomic CAG nucleotides |
| 08/05/2004 | US20040152777 Therapeutically active compounds |
| 08/05/2004 | US20040152776 Fatty acid treatment for cardiac patients |
| 08/05/2004 | US20040152775 Using a compound containing a amine and a sulfinate group; gastrointestinal disorders |
| 08/05/2004 | US20040152774 Method of protecing against tissue extra vasation injury |
| 08/05/2004 | US20040152773 Animal growth regulator; infants |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152771 Mixture with biguanidine drug; antidiabetic agents; insulin resistance |
| 08/05/2004 | US20040152769 Anticancer, antitumor agents; viricides; antiarthritic agents |
| 08/05/2004 | US20040152768 NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate |
| 08/05/2004 | US20040152766 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 08/05/2004 | US20040152765 Skin disorders; exfoliation; mixture with other acids |
| 08/05/2004 | US20040152764 Tocopherol compound |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152760 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 08/05/2004 | US20040152759 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 08/05/2004 | US20040152757 Carvedilol |
| 08/05/2004 | US20040152755 Aids viricide |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152752 Administering cyclooxygenase inhibitor; topical administering |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152750 Hypoglycemic agents; antidiabetic agents; antilipemic agents; dietetics |
| 08/05/2004 | US20040152748 Mixture containing a 2-methyl-3-isothiazolone compound |
| 08/05/2004 | US20040152747 Central nervous system disorders; Alzheimer's disease; strokes; Down's syndrome; cognition activators; anxiolytic agents; antidepressants; sleep disorders; antiinflammatory agents |
| 08/05/2004 | US20040152746 Treatment of scarring and related conditions using ppar-gamma activators |
| 08/05/2004 | US20040152743 Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals |
| 08/05/2004 | US20040152739 Bone disorders; cardiovascular disorders; gastrointestinal disorders; angiogenesis inhibitors; metabolism disorders; central nervous system disorders; traumas; skin disorders; inflammatory bowel disorders; anticancer agents |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152737 Attention deficit hypoactivity disorders |
| 08/05/2004 | US20040152735 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine |
| 08/05/2004 | US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 08/05/2004 | US20040152733 Menopause therapy |
| 08/05/2004 | US20040152732 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds |
| 08/05/2004 | US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152729 Using a 4-((ho-phenyl)-nh-)quinoline compound |
| 08/05/2004 | US20040152727 Novel use |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152722 Use of phencynonate hydrochloride |
| 08/05/2004 | US20040152721 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 08/05/2004 | US20040152720 Powdered medicaments containing a tiotropium salt and salmeterol xinafoate |
| 08/05/2004 | US20040152719 Quinolones with anti-HIV activity |
| 08/05/2004 | US20040152716 Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonane compounds and methods of treatment relating to anti-arrhythmic events |
| 08/05/2004 | US20040152714 Benzylaminopyrimidines |
| 08/05/2004 | US20040152713 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | US20040152712 sEXUAL DISORDERS; ERECTILE DYSFUNCTION |
| 08/05/2004 | US20040152710 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 08/05/2004 | US20040152709 New compound for the treatment of impotence |
| 08/05/2004 | US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism |
| 08/05/2004 | US20040152706 Antidepressants; Alzheimer's disease; Parkinson's disease; anxiolytic agents; analgesics; strokes; brain disorders; hypotensive agents; obesity; antihistamines; immunosuppressants; antiulcer agents |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152702 Benzoxazol derivatives |
| 08/05/2004 | US20040152700 Novel use of 2-phenyl-substituted imidazotriazinones |
| 08/05/2004 | US20040152699 Compounds |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152696 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| 08/05/2004 | US20040152695 Antiinflammatory agents; inflammatory bowel disorders; skin disorders; antiarthritic agents; multiple sclerosis; antidepressants; autism; lyme disease |
| 08/05/2004 | US20040152694 Methods and compositions for treating inflammatory disorders of the airways |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152691 Antiproliferative agents |
| 08/05/2004 | US20040152689 Therapeutic agents useful for treating pain |
| 08/05/2004 | US20040152688 Aminopyridine derivatives as estrogen receptor modulators |
| 08/05/2004 | US20040152687 Having anticancer and antitumor effects; porphyrin moiety selectively localizes in tumors, while the polyamine moiety serves as a cytotoxic agent |
| 08/05/2004 | US20040152686 Metal complexes and therapeutic uses thereof |
| 08/05/2004 | US20040152685 Agents and methods for the prevention of initial onset and recurrence of existing cancers |
| 08/05/2004 | US20040152684 Administering at least one 17 alpha -fluoralkylated progesterone receptor antagonist to the female subject during the post-ovulatory phase of the endometrial cycle inhibiting the occurrence of advanced endometrium maturation |
| 08/05/2004 | US20040152683 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/05/2004 | US20040152682 Stabilized steroid composition and method for its preparation |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152674 Pharmaceutically active compounds and methods of use thereof |
| 08/05/2004 | US20040152673 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152672 Indole compounds useful for the treatment of cancer |
| 08/05/2004 | US20040152669 Anti-bacterial agents based upon oxoanion binding |
| 08/05/2004 | US20040152667 4-Alkenylthiazoles comprising epoxide functionality, and methods of use thereof |
| 08/05/2004 | US20040152666 Introducing a peritoneal dialysis solution comprising N-acetylglucosamine (NAG) as an osmotic agent into the peritoneal cavity of the patient for therapy of renal failure |
| 08/05/2004 | US20040152665 Administering to mammal an effective amount of a N-acylated-2-glucosamine derivative for enhancing weight gain or growth of a mammal exhibiting decreased weight or growth |
| 08/05/2004 | US20040152664 Prednisolone compositions |